Search
Dayang Biotech: Zhejiang Xinzhichun Semiconductor Anticipated to Commence Trial Production in October
2025-10-13 /
Read about 0 minute
Author：小编
On October 13th, Dayang Biotech revealed on an interactive platform that it possesses a 30% equity interest in Zhejiang Xinzhichun Semiconductor Materials Co., Ltd. This company is dedicated to manufacturing graphite - based high - purity ceramic products. These products find applications in crucial components of semiconductor equipment and epitaxial equipment, including LEDs. At present, the primary construction work of the project has been largely finalized, and it is projected to embark on the trial production phase in October.
-
C114 Communication Network -
Communication Home
7 X 24 Track global technological trends
